Search

everythinglearnresearchcommunity

for

Search:↓

Hemp seed oil shows promise in treating localized alopecia areata.

Hispanic/Latinx patients with alopecia areata often have it before age 40, with females and certain health conditions like rheumatoid arthritis more commonly affected.

The analysis found that alopecia areata, a hair loss condition, is not very common in Australia, affecting about 0.13% of people, with new cases most often seen in males aged 19 to 34 years.

Bimatoprost and clobetasol are both effective for scalp hair loss, but bimatoprost works faster, has fewer side effects, and grows more colored hair.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Alopecia areata is a genetic and immune-related hair loss condition that is often associated with other autoimmune diseases and does not typically cause permanent damage to hair follicles.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Two people had unusual ring-shaped hair loss due to an autoimmune disorder.

JAK inhibitors like tofacitinib may effectively treat Alopecia Areata.

Platelet-rich plasma injections can effectively treat alopecia areata barbae.

Upadacitinib cleared scalp alopecia areata in three patients and also improved atopic dermatitis with minimal side effects.

Yellow dots and short vellus hairs are the most common signs of Alopecia Areata (AA), and trichoscopy can help diagnose AA and track treatment progress.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

The combination of vitamin D analogues with potent steroids is a favorable treatment for alopecia areata with fewer side effects.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Tofacitinib is effective and has minor, reversible side effects for treating severe hair loss in Iran.

Both DPCP alone and with PRP are effective and safe for treating severe alopecia areata.

Phototherapy helps some patients with alopecia areata regrow hair, especially those with hair at treatment start and less severe forms of the condition.

Low vitamin D levels are linked to severe and active alopecia areata.

A woman's hair loss was initially misdiagnosed as scarring hair loss but was actually a treatable autoimmune hair loss.

The study found that alopecia areata is strongly linked to autoimmune diseases and may indicate a genetic predisposition to such conditions.

The most common hair loss type at specialist clinics is androgenetic alopecia, especially in younger men, followed by alopecia areata and telogen effluvium, with differences seen across regions.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

Diphencyprone can help some children with alopecia areata regrow hair, but it often causes side effects.

Children with alopecia areata should only have thyroid screening if they have Down syndrome, a history of atopy, family history of thyroid disease, or signs of thyroid problems.

Some breast cancer patients developed permanent hair loss after chemotherapy and hormonal therapy, showing patterns similar to common baldness and alopecia areata.

Tofacitinib helped regrow hair in patients with alopecia, with few side effects.

Dupilumab may help children with alopecia areata and atopic dermatitis regrow hair.

Yellow dots are common in severe alopecia areata.